Aminoglycoside Extended Interval: Hartford-style eligibility flags for once-daily aminoglycoside use.
Assessment Tier
Use Caution
Score 0
Assess patient-specific exclusions before using Hartford-style dosing.
Verified
Last Review: 2026-07-17
Use during early bedside triage when infection severity or treatment escalation is uncertain.
Support clinician judgement with a structured review of the highest-yield risk factors.
Standardise communication between admitting, ID, ICU, and pharmacy teams.
Stable renal function (+2)
Dialysis / severe renal failure (-3)
Endocarditis present (-2)
Extensive burns / cystic fibrosis (-2)
Gram-negative infection where synergy not required (+2)
Interpret the result together with source control, microbiology, host factors, and trajectory.
Escalate imaging, cultures, or specialist review when the tool lands in a high-risk tier.
Reassess dynamically if the patient deteriorates or new microbiology becomes available.
This tool supports structured infectious-disease decision making but does not replace clinician judgement or local guideline pathways.
This OpiCalc infectious-disease entry reflects commonly used guideline criteria and bedside risk features used in contemporary clinical practice.
Last Comprehensive Review: 2026-07-17